Review of vancomycin-induced renal toxicity: an update

176Citations
Citations of this article
230Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In recent times the use of larger doses of vancomycin aimed at curbing the increasing incidence of resistant strains of Staphylococcus aureus has led to a wider report of acute kidney injury (AKI). Apart from biological plausibility, causality is implied by the predictive association of AKI with larger doses, longer duration, and graded plasma concentrations of vancomycin. AKI is more likely to occur with the concurrent use of nephrotoxic agents, and in critically ill patients who are susceptible to poor renal perfusion. Although most vancomycin-induced AKI cases are mild and therefore reversible, their occurrence may be associated with greater incidence of end-stage kidney disease and higher mortality rate. The strategy for its prevention includes adequate renal perfusion and therapeutic drug monitoring in high-risk individuals. In the near future, there is feasibility of renoprotective use of antioxidative substances in the delivery of vancomycin.

References Powered by Scopus

Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury

5823Citations
N/AReaders
Get full text

Acute renal failure in critically ill patients: A multinational, multicenter study

3610Citations
N/AReaders
Get full text

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

1582Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Association of Duration and Type of Surgical Prophylaxis with Antimicrobial-Associated Adverse Events

226Citations
N/AReaders
Get full text

Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis

188Citations
N/AReaders
Get full text

The Whole Price of Vancomycin: Toxicities, Troughs, and Time

143Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bamgbola, O. (2016, June 1). Review of vancomycin-induced renal toxicity: an update. Therapeutic Advances in Endocrinology and Metabolism. SAGE Publications Ltd. https://doi.org/10.1177/2042018816638223

Readers over time

‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25015304560

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 70

69%

Researcher 19

19%

Professor / Associate Prof. 10

10%

Lecturer / Post doc 3

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 63

53%

Pharmacology, Toxicology and Pharmaceut... 44

37%

Biochemistry, Genetics and Molecular Bi... 7

6%

Agricultural and Biological Sciences 5

4%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 10

Save time finding and organizing research with Mendeley

Sign up for free
0